CHRONIC MYELOGENOUS LEUKEMIA WITH TRANSLOCATIONS (3Q-; 9Q+) AND (17Q-; 22Q+). POSSIBLE CRUCIAL CYTOGENETIC EVENTS IN THE GENESES OF CMLOSHIMURA M; OHYASHIKI K; VEHARA M et al.1981; HUM. GENET.; ISSN 0340-6717; DEU; DA. 1981; VOL. 57; NO 1; PP. 48-51; BIBL. 21 REF.Article

Treatment of acute myelogenous leukemia in adults with N⁴-behenoyl-1-β-D-arabinofuranosylcytosineKIMURA, K; OHNO, R; MASAOKA, T et al.Cancer. 1985, Vol 56, Num 8, pp 1913-1917, issn 0008-543XArticle

Phase I clinical and pharmacokinetic study of N⁴-behenoyl-1-β-D-arabinofuranosylcytosineKIMURA, K; OHNO, R; MASAOKA, T et al.Medical oncology and tumor pharmacotherapy. 1986, Vol 3, Num 1, pp 15-24, issn 0736-0118Article

Restorative activity of muroctasin on leukopenia associated with anticancer treatmentTSUBURA, E; NOMURA, T; HORIUCHI, A et al.Arzneimittel-Forschung. 1988, Vol 38, Num 7, pp 1070-1074, issn 0004-4172Article

Phase I clinical and pharmacokinetic study of orally administered N⁴-palmitoyl-1-β-D-arabinofuranosylcytosineOHNO, R; KIMURA, K; KIMURA, I et al.Medical oncology and tumor pharmacotherapy. 1987, Vol 4, Num 2, pp 67-73, issn 0736-0118Article

Treatment of multiple myeloma with recombinant human leukocyte A interferonOHNO, R; KIMURA, K; TAKAKU, F et al.Cancer treatment reports. 1985, Vol 69, Num 12, pp 1433-1435, issn 0361-5960Article